NMDA receptor dysfunction may be involved in the pathophysiology of schizophrenia. Based on this hypothesis, we screened 48 Japanese patients with schizophrenia for mutations in the coding region of the NMDAR2B subunit gene (GRIN2B). An association study between the identified DNA sequence variants and schizophrenia was performed in 268 Japanese patients with schizophrenia and 337 Japanese control subjects. Eight single nucleotide polymorphisms were detected, all of which were synonymous. The association sample showed statistically significant excesses of homozygosity for the polymorphisms in the 3' region of the last exon in the patients with schizophrenia (P = 0.004) and higher frequency of the G allele of the 366C/G polymorphism (corrected P = 0.04) in the patients than in the controls. Although we did not detect NMDAR2B protein variants, our findings support the possibility that the GRIN2B gene or a locus in linkage disequilibrium with it may confer susceptibility to schizophrenia. Replication studies in independent samples are warranted. Molecular Psychiatry (2001) 6, 211-216.
The glutamate dysfunction hypothesis is one of the main explanatory hypotheses for the pathophysiology of schizophrenia. It originated from the observation that phencyclidine (PCP) intoxication closely mimics schizophrenia. 1 At serum levels that produce schizophrenic symptoms, PCP acts as a noncompetitive antagonist of the N-methyl-d-aspartate (NMDA) receptors. 2 Ketamine and MK-801, two additional noncompetitive antagonists of NMDA receptors, also produce schizophrenic symptoms and exacerbate symptoms in patients with schizophrenia. [3] [4] [5] NMDA receptors, together with alpha-amino-3-hydroxy-5-methyl-4-isozaxole propionic acid (AMPA) and kainate receptors, comprise the known ionotropic glutamate receptors. 6 Functional NMDA receptors are composed of a common NMDAR1 subunit and one of four NMDAR2 subunits (NMDAR2A-NMDAR2D) combined in an undetermined ratio to make the heteromeric receptor complex. 7, 8 Knockout mice lacking each of the known NMDA receptor subunits have been generated. [9] [10] [11] [12] [13] [14] [15] Mice lacking NMDAR1 or NMDAR2B protein die perinatally, 9, 10, 14 knockdown mice expressing only 5% of normal levels of the essential NMDAR1 subunit survive to adulthood but display behavioral abnormalities including increased motor activity and stereotypy and deficits in social and sexual interactions. These behavioral alterations are similar to those observed in pharmacologically induced animal models of schizophrenia and can be ameliorated by treatment with haloperidol or clozapine. These findings support a model in which reduced NMDA receptor activity results in schizophrenic-like behavior.
16
NMDAR2B mRNA is found throughout the entire embryonic brain in mice, but its expression becomes restricted to the forebrain postnatally. 17, 18 There is a high degree of regional specialization with respect to specific NMDA receptors within the basal ganglia, and NMDAR2B is abundant in the striatum.
19 NMDAR2B mRNA expression is regulated by cortico-striatal fibers in a topographic manner. 20 NMDAR2B expression has been shown to be strongest in layer II neurons in prefrontal cortex. 21 Levels of NMDAR2B mRNAs have been shown to decrease after acute administration of sulpiride but increase after chronic administration of sulpiride. 22 Treatment with flupenthixol has produced similar results; 23 however, no change after antipsychotic drug treatment has been reported. 24, 25 Linkage between the NMDA receptor subunit gene loci and schizophrenia has been examined by several groups. The region of the GRIN2B locus was formerly excluded for values of lambda S greater than 1.5 in a group of families from England, Wales, Scotland and Southern Ireland. 26 No evidence for linkage resulted from a study of families from southeast England, Wales, and Japan. 27 However, linkage was not excluded in families of European descent populations. 28 In a linkage study of affected schizophrenic individuals from southern African Bantu-speaking families, a LOD score of 0.453 was found at marker D12S77 on chromosome 12p12 near the NMDAR2B (GRIN2B) gene. 29 The genetic initiative of the US National Institute of Mental Health reported a nonparametric linkage (NPL) score of 1.53 near the GRIN2B locus in European-American schizophrenia pedigrees. 30 These linkage studies preclude a major role for the GRIN2B locus in susceptibility to schizophrenia. However, the possibility of a minor role for this gene remains.
In this study, we carried out systematic mutation search of the NMDAR2B (GRIN2B) gene in 48 randomly-selected schizophrenia patients by single-strand conformation polymorphism (SSCP) analysis using the GenePhor System (Pharmacia, Piscataway, NJ, USA). The sequence of the GRIN2B gene mRNA was based on HSU88963. The genomic structure of the coding region of the GRIN2B gene was determined through BLAST searches of the sequences AC007916, AC007784, AC007397, and AC007535. The gene consists of 13 exons; the coding sequence is encompassed by exons 2 through 13. All coding exons and exonintron junctions were amplified by polymerase chain reaction (PCR) with the primers and conditions listed in a Web site (http://www.md.tsukuba.ac.jp/public/ basic-med/m-genetics/GRIN2B.html).
Eight single nucleotide polymorphisms were detected: 15G/T, 366C/G, 1665C/T, 2664C/T, 4197T/C, 4615C/T, 5806A/C, and 5988T/C (Figures 1 and 2 ; Table 1 ). Although the first five polymorphisms are in the coding sequence, they are silent polymorphisms: 15G/T (GCG/GCT, Ala5/Ala5), 366C/G (CCC/CCG, Pro122/Pro122), 1665C/T (AGC/AGT, Ser555/Ser555), 2664C/T (ACC/ACT, Thr888/Thr888), 4197T/C (CAT/CAC, His1399/His1399). The 1665C/T, 2664C/T, 4197T/C, 4615C/T, 5806A/C, and 5988T/C polymorphisms were in almost complete linkage disequilibrium with each other (http://www.md.tsukuba.ac.jp/ public/basic-med/m-genetics/GRIN2B.html). Table 2 shows the genotypic and allelic distributions of the five common polymorphisms in extended 268 Japanese patients with schizophrenia and 337 Japanese control subjects. The results of the 15G/T, 1665C/T, and 4615C/T polymorphisms were omitted because of the low frequencies of the detected alleles. The allele frequencies of the T allele of the 15G/T, 1665C/T, and 4615C/T polymorphisms were 0.06, 0.01, and 0.00 in the controls and 0.08, 0.01, and 0.01 in the schizophrenic patients, respectively. The genotypic distributions of the 4197T/C, 5806A/C, and 5988T/C polymorphisms deviated significantly from HardyWeinberg equilibrium in the schizophrenia group (Table 2) . Frequencies of heterozygotes for these polymorphisms were lower than expected Hardy-Weinberg equilibrium. A statistically significant allelic difference in the 366C/G polymorphism was observed between the patient and control groups (P = 0.02, (corrected P = 0.04), odds ratio (OR) = 1.29, 95% confidence interMolecular Psychiatry val (CI) 1.03-1.62) ( Table 2) . No significant differences in the allele frequencies of the other polymorphisms were observed between the patient and control groups.
Haplotype distributions of the five common polymorphisms were estimated by the EM algorithm. If the polymorphisms are independent, 32 haplotypes are theoretically possible. However, only 13 haplotypes were observed, and there were only six haplotypes with a frequency greater than 1% (Table 3) . Distributions of all of the observed haplotypes did differ statistically significantly between the patient and control groups (P = 0.04), but we considered the significance to Bold letters indicate haplotypes with a frequency greater than 1%. P = 0.04 for difference in overall haplotype distribution. *Uncorrected P = 0.01; corrected P = 0.058, when compared to the remaining haplotypes.
be only marginal. When each of the six common haplotypes was tested for an association, the frequency of the GTTAT haplotype (the G allele of the 366C/G, the T allele of the 2664C/T, the T allele of the 4197T/C, the A allele of the 5806A/C, and the T allele of the 5988T/C) was higher in patients (0.234) than in controls (0.178) (P = 0.01, OR = 1.40, 95% CI 1.06-1.86). However, after correction for multiple comparisons, the difference in haplotype frequency was not significant because we tested six haplotypes (corrected P = 0.058). Although eight single nucleotide polymorphisms were identified by mutation analysis of the GRIN2B gene, none of these polymorphisms caused changes in the amino acid sequence of the NMDAR2B protein.
Therefore, it appears that there are no common molecular variants of the NMDAR2B protein in Japanese patients with schizophrenia. However, rare molecular variants could not be excluded because we searched only 48 patients, and the detection power of this sample size is 80% for variants with allele frequencies less than 4%, even if SSCP analysis detects all nuclear variants. Moreover, the ability to detect mutations by SSCP is limited.
At present we have no explanation for the departure from Hardy-Weinberg equilibrium of the 4197T/C polymorphism and the polymorphisms in the 3Ј untranslated region (UTR) of the GRIN2B gene in the schizophrenia patients. Excess homozygosity could exist in a population in which sub-populations with different allele frequencies had mixed recently. However, this is unlikely in Japan. The second possibility is that individuals homozygous for these polymorphisms possess the genotype susceptible to schizophrenia. This may be analogous to the excess homozygosity of the Ser9Gly polymorphism of the DRD3 gene in schizophrenia patients. 31 However, even if this is the case, the pathological mechanism would not be clear until the functional alterations of these polymorphisms are understood. A third possibility is that the deviation from Hardy-Weinberg equilibrium observed in this study occurred by chance. It is necessary to examine other schizophrenic populations to determine whether our observations will be supported by further evidence.
We observed a significant difference in the allele frequency of the 366C/G polymorphism between patients and control individuals. When the haplotypes are taken into account, the greatest contribution to the increased frequency of the G allele of the 366C/G polymorphism appears to be the chromosome of the GTTAT haplotype. Therefore, the association is haplotypic rather than allelic. This finding suggests that the GRIN2B gene or a locus in linkage disequilibrium with it confers susceptibility to schizophrenia. However, case-control studies are susceptible to positive and negative results produced by hidden population stratifications. Thus, further studies are necessary to confirm this weak association between the GRIN2B gene locus and schizophrenia.
Materials and methods

Subjects
The schizophrenia patients analyzed in this study were 268 unrelated Japanese patients (154 men and 114 women with a mean ± SD age of 45.8 ± 11.5 years). They were recruited from among patients who were being treated at six hospitals near Tokyo in Japan. All patients satisfied the ICD-10 or DSM-III-R criteria for schizophrenia. The control subjects consisted of 337 anonymous, unrelated Japanese individuals (194 men and 143 women with a mean ± SD age of 48.2 ± 12.5 years). Among them, 135 hospital staff members who were psychosis free, but the others who were recruited from apparently healthy employees seeking annual medical examinations, were not evaluated for psychiatric disorders by psychiatrists. This study was approved by the Ethics Committees of Tsukuba University and Tokyo Medical and Dental University. All subjects gave written informed consent to participate in this study.
DNA analysis
Mutations were searched in 48 randomly-selected schizophrenia patients by single-strand conformation polymorphism (SSCP) analysis using the GenePhor System (Pharmacia, Piscataway, NJ, USA). Subsequently, PCR products with altered SSCP bands were sequenced using a Dye Terminator Cycle Sequencing kit and an ABI PRISM 310 DNA Sequencer (Perkin Elmer, Wellesley, MA, USA). The nucleotide variants detected in this study were genotyped by restriction fragment length polymorphism (RFLP) analysis after PCR amplification (Table 1) .
Statistical procedures
The following statistical procedures were carried out using Arlequin ver 1.1 (http://anthropologie. unige.ch/arlequin): evaluation of deviation of genotype distribution from Hardy-Weinberg equilibrium, estimation of maximum-likelihood haplotype frequencies, linkage disequilibrium values (D), standardized disequilibrium values (DЈ = D/D max ), evaluation for significance of linkage disequilibrium, and differences in allelic and haplotypic distribution between the patient and control groups. The haplotype counts were estimated based on EM estimates of haplotype frequency. P-values were obtained after more than 300 000 Markov chain steps. A P-value Ͻ0.05 was considered significant in tests for Hardy-Weinberg equilibrium. When allelic distributions of each polymorphism were compared between the patient and control, groups, correction for multiple testing was made by two (P Ͻ 0.025) because, among five polymorphisms we tested, four were in almost complete linkage disequilibrium. A P-value Ͻ0.05 was considered significant in tests for group differences in the global haplotypic distributions. To evaluate the statistical significance for each haplotype, Fisher's exact test was carried out by comparing the numbers of a specific haplotype vs that of the others. A P-value Ͻ0.009 was considered significant because there were six haplotypes with frequencies greater than 1%, and we evaluated these six haplotypes.
